USF Health reflects on a year of COVID-19
In the video above, USF Health leaders and frontline workers look back on the successes, challenges and emotions they experienced while dealing with an incredibly challenging year amid […]
New USF Institute for Microbiomes created to advance human and environmental health
TAMPA, Fla (July 21, 2021) – USF Health today announced the launch of a major university-wide institute dedicated to harnessing the huge populations of bacteria, viruses, fungi and other […]
Enhanced alliance progresses for Tampa General Hospital and University of South Florida, as name is announced and search for inaugural leader begins
The new organization is on target for an October 2021 launch, and will form one of the largest academic medical groups in the state of Florida. Tampa, FL […]
USF awarded four-year, $69.9 million NIH grant to continue type 1 diabetes research
The Environmental Determinants of Diabetes in the Young study is led by USF Health’s Jeffrey Krischer, who has built a worldwide epidemiological hub for T1D research at USF […]
Timely treatment with COVID-19 monoclonal antibodies can reduce hospitalizations, pandemic’s stress on health care systems
A study by USF Health and Tampa General Hospital among the first to assess effectiveness of MABs in a practical setting when given to patients at […]
Gene profile in blood predicts risk of poor outcomes, death for patients with COVID-19
A previously validated gene profile in blood that predicts idiopathic pulmonary fibrosis mortality was repurposed to assess the likelihood of COVID-19 survival, a USF Health-led study reports Tampa, […]
USF Health’s ambulatory surgery center earns national AAAHC accreditation
USF Health’s Endoscopy and Surgery Center recently earned accreditation from the Accreditation Association for Ambulatory Health Care (AAAHC), which certifies that it meets and exceeds nationally-recognized standards of […]
Antiparasitic drug shows promise as an early treatment for mild-to-moderate COVID-19
Early treatment with the FDA-approved antiparasitic drug nitazoxanide prevents mild or moderate COVID-19 symptoms from progressing to severe illness and hospitalization, a clinical study co-led by USF Health’s […]
NIH study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines begins at USF Health
USF Health’s Dr. Thomas Casale leads one of only two academic allergy-research centers in Florida participating in the national trial TAMPA, Fla. (April 14, 2021) — USF Health […]
USF Health-led global team searches for vaccine to prevent P. vivax malaria
The five-year, $4.9-million NIH project aims to help eliminate the world’s most geographically widespread type of malaria With the support of a five-year, $4.86-million National Institutes of Health […]
Blog
Search USF Health News
Can’t find a news post?
USF Health Communications
Media relations, internal/marketing communications, social media, community outreach and more.